What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman’s Day

  • Authors: Piccoli GB1,2, Alrukhaimi M3, Zhi-Hong L.4, Zakharova E5,6,7, Levin A8
  • Affiliations:
    1. Department of Clinical and Biological Sciences, University of Torino, Torino, Italy
    2. Nephrology department, Centre Hospitalier Le Mans, Le Mans, France
    3. Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
    4. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
    5. Nephrology department, S.P. Botkin Moscow City Hospital, Moscow, Russia
    6. Department of Nephrology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia
    7. Department of Nephrology, Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
    8. Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada
  • Issue: Vol 90, No 6 (2018)
  • Pages: 4-14
  • Section: Editorial
  • URL: https://journals.rcsi.science/0040-3660/article/view/32737
  • DOI: https://doi.org/10.26442/terarkh20189064-14
  • ID: 32737

Cite item

Full Text

Abstract

On behalf of the World Kidney Day Steering Committee Chronic kidney disease affects approximately 10% of the world’s adult population: it is within the top 20 causes of death worldwide, and its impact on patients and their families can be devastating. World Kidney Day and International Women’s Day in 2018 coincide, thus offering an opportunity to reflect on the importance of women’s health and specifically their kidney health, on the community, and the next generations, as well as to strive to be more curious about the unique aspects of kidney disease in women so that we may apply those learnings more broadly. Girls and women, who make up approximately 50% of the world’s population, are important contributors to society and their families. Gender differences continue to exist around the world in access to education, medical care, and participation in clinical studies. Pregnancy is a unique state for women, offering an opportunity for diagnosis of kidney disease, but also a state where acute and chronic kidney diseases may manifest, and which may impact future generations with respect to kidney health. There are various autoimmune and other conditions that are more likely to impact women with profound consequences for child bearing, and on the fetus. Women have different complications on dialysis than men, and are more likely to be donors than recipients of kidney transplants. In this editorial, we focus on what we do and do not know about women, kidney health, and kidney disease, and what we might learn in the future to improve outcomes worldwide.

About the authors

G B Piccoli

Department of Clinical and Biological Sciences, University of Torino, Torino, Italy; Nephrology department, Centre Hospitalier Le Mans, Le Mans, France

Email: gbpiccoli@yahoo.it
проф., отд. клинических и биологических наук, Туринский университет, Турин, Италия; отд-ние нефрологии, Госпитальный центр Ле-Ман, Ле-Ман, Франция Турин, Италия

M Alrukhaimi

Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates

проф., oтд-нием медицины, Медицинский колледж Дубай Дубай, Объединенные Арабские Эмираты

Liu Zhi-Hong

National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

проф., Национальный центр клинических исследований заболеваний почек, Госпиталь Джинлинг, Медицинская школа Нанкинского университета Нанкин, Китай

E Zakharova

Nephrology department, S.P. Botkin Moscow City Hospital, Moscow, Russia; Department of Nephrology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia; Department of Nephrology, Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia

к.м.н., зав. отд. нефрологии городской клинической больницы им. С.П. Боткина, доц. каф. нефрологии ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России, доц. каф. нефрологии ФГБОУ ДПО «Российская медицинская академия непрерывного последипломного образования» Минздрава России Москва, Россия

A Levin

Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada

Email: alevin@providencehealth.bc.ca
проф., отд. медицины, отд-ние нефрологии Университета Британской Колумбии Ванкувер, Британская Колумбия, Канада

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-602. doi: 10.1016/S0140-6736(16)31678-6
  2. Von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre - eclampsia: development and validation of the full PIERS model. Lancet. 2011;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7
  3. Mol B.W.J, Roberts C.T, Thangaratinam S, Magee L.A, et al. Pre - eclampsia. Lancet. 2016;387(10022):999-1011. doi: 10.1016/S0140-6736(15)00070-7
  4. Vikse B.E, Irgens L.M, Leivestad T, et al. Preeclampsia and the risk of end - stage renal disease. N Engl J Med. 2008;359(8):800-9. doi: 10. 1056/NEJMoa0706790
  5. Theilen L.H, Fraser A, Hollingshaus M.S, et al. All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol. 2016;128(2):238-44.
  6. Piccoli G.B, Cabiddu G, Attini R, et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015;26(8):2011-22. doi: 10.1681/ASN.2014050459
  7. Zhang J-J, Ma X-X, Hao L, et al. A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy. Clin J Am Soc Nephrol. 2015;10(11):1964-78. doi: 10.2215/ CJN.09250914
  8. Alkhunaizi A, Melamed N, Hladunewich M.A. Pregnancy in advanced chronic kidney disease and end - stage renal disease. Curr Opin Nephrol Hypertens. 2015;24(3):252-9. doi: 10.1097/MNH.0000000000000119
  9. Piccoli G.B, Cabiddu G, Castellino S, et al. A best practice position statement on the role of the nephrologist in the prevention and follow - up of preeclampsia: the Italian study group on kidney and pregnancy. J Nephrol. 2017;30(3):307-17. doi: 10.1007/s40620-017-0390-1
  10. Liu Y, Ma X, Zheng J, Liu X, Yan T. Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta - analysis. BMC Pregnancy Childbirth. 2017;17(1):235. doi: 10. 1186/s12884-017-1402-9
  11. Jim B, Garovic V.D. Acute Kidney Injury in Pregnancy. Semin Nephrol. 2017;37(4):378-85. doi: 10.1016/j.semnephrol.2017.05.010
  12. Acharya A. Management of Acute Kidney Injury in Pregnancy for the Obstetrician. Obstet Gynecol Clin North Am. 2016 Dec;43(4):747-65. doi: 10.1016/j.ogc.2016.07.007
  13. Iseki K. Gender differences in chronic kidney disease. Kidney Int. 2008;74(4):415-7. doi: 10.1038/ki.2008.261
  14. Nitsch D, Grams M, Sang Y, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta - analysis. BMJ. 2013;346:f324. doi: 10.1136/bmj.f324
  15. Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661-71. doi: 10.1053/j.ajkd.2008.06.023
  16. Weiner D.E, Tighiouart H, Elsayed E.F, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50(3):217-24. doi: 10.1016/j.jacc.2007.03.037
  17. Oladapo O.T, Adetoro O.O, Ekele B.A, et al. When getting there is not enough: a nationwide cross - sectional study of 998 maternal deaths and 1451 near - misses in public tertiary hospitals in a low - income country. BJOG. 2016;123(6):928-38. doi: 10.1111/1471-0528.13450
  18. Tranquilli A.L, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104. doi: 10.1016/j.preghy.2014.02.001
  19. Liu Y, Bao H, Jiang Z, et al. Pregnancy - related Acute Kidney Injury and a Review of the Literature in China. Intern Med. 2015;54(14): 1695-703. doi: 10.2169/internalmedicine.54.3870
  20. Prakash J, Pant P, Prakash S, et al. Changing picture of acute kidney injury in pregnancy: Study of 259 cases over a period of 33 years. Indian J Nephrol. 2016;26(4):262-7. doi: 10.4103/0971-4065.161018
  21. Ibarra-Hernández M, Orozco-Guillén O.A, de la Alcantar-Vallín M.L, et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from México. J Nephrol. 2017;30(6):773-80. doi: 10.1007/s40620-017-0444-4
  22. Blázquez A, García D, Rodríguez A, et al. Is oocyte donation a risk factor for preeclampsia? A systematic review and meta - analysis. J Assist Reprod Genet. 2016 Jul;33(7):855-63. doi: 10.1007/s10815-016-0701-9
  23. O’Gorman N, Wright D, Poon L.C, et al. Multicenter screening for pre - eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756-60. doi: 10.1002/uog.17455
  24. Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374(1):13-22. doi: 10.1056/NEJMoa1414838
  25. Garovic V.D. The Role of the Podocyte in Preeclampsia. Clin J Am Soc Nephrol. 2014;9(8):1337-40. doi: 10.2215/CJN.05940614
  26. Wide-Swensson D, Strevens H, Willner J. Antepartum percutaneous renal biopsy. Int J Gynaecol Obstet. 2007;98(2):88-92. doi: 10.1016/ j.ijgo.2007.03.049
  27. Shiiki H, Dohi K, Hanatani M, et al. Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome. Am J Nephrol. 1990;10(3):205-12. PMID: 2382682
  28. Linsell L, Malouf R, Morris J, et al. Risk Factor Models for Neurodevelopmental Outcomes in Children Born Very Preterm or With Very Low Birth Weight: A Systematic Review of Methodology and Reporting. Am J Epidemiol. 2017;185(7):601-12. doi: 10.1093/aje/kww135
  29. Guellec I, Lapillonne A, Marret S, et al. Effect of Intra - and Extrauterine Growth on Long-Term Neurologic Outcomes of Very Preterm Infants. J Pediatr. 2016;175:93-9.e1. doi: 10.1016/j.jpeds.2016.05.027
  30. Moore T, Hennessy E.M, Myles J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ. 2012;345:e7961. doi: 10.1136/ bmj.e7961
  31. Guillén Ú, De Mauro S, Ma L, et al. Relationship Between Attrition and Neurodevelopmental Impairment Rates in Extremely Preterm Infants at 18 to 24 Months: A Systematic Review. Arch Pediatr Adolesc Med. 2012;166(2):178-84. doi: 10.1001/archpediatrics.2011.616
  32. Ranke M.B, Schweizer R, Rodemann S.M, et al. Schoolchildren born VLBW or VLGA show height - related changes in body composition and muscle function but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study. J Pediatr Endocrinol Metab. 2016;29(2):163-72. doi: 10.1515/jpem-2015-0266
  33. Castanys-Muñoz E, Kennedy K, Castañeda-Gutiérrez E, et al. Systematic review indicates postnatal growth in term infants born small - for - gestational - age being associated with later neurocognitive and metabolic outcomes. Acta Paediatr. 2017;106(8):1230-8. doi: 10.1111/apa.13868
  34. Ong K.K, Kennedy K, Castañeda-Gutiérrez E, et al. Postnatal growth in preterm infants and later health outcomes: a systematic review. Acta Paediatr. 2015;104(10):974-86. doi: 10.1111/apa.13128
  35. Low Birth Weight and Nephron Number Working Group. The Impact of Kidney Development on the Life Course: A Consensus Document for Action. Nephron. 2017;136(1):3-49. doi: 10.1159/000457967
  36. Luyckx V.A, Bertram J.F, Brenner B.M, et al. Effect of fetal and child health on kidney development and long - term risk of hypertension and kidney disease. Lancet. 2013;382(9888):273-83. doi: 10.1016/S0140-6736(13)60311-6
  37. Luyckx V.A, Brenner B.M. Birth weight, malnutrition and kidney - associated outcomes - a global concern. Nat Rev Nephrol. 2015;11(3):135-49. doi: 10.1038/nrneph.2014.251
  38. Davison J.M, Lindheimer M.D. Pregnancy and chronic kidney disease. Semin Nephrol. 2011;31(1):86-99. doi: 10.1016/j.semnephrol. 2010.10.008
  39. Hall M. Pregnancy in Women with CKD: A Success Story. Am J Kidney Dis. 2016;68(4):633-9. doi: 10.1053/j.ajkd.2016.04.022
  40. Nevis I.F, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol. 201;6(11):2587-98. doi: 10.2215/CJN.10841210
  41. Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 2016;29(3):277-303. doi: 10.1007/s40620-016-0285-6
  42. Garg A.X, Nevis I.F, Mc Arthur E et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med. 2015; 372(2):124-33. doi: 10.1056/NEJMoa1408932
  43. Josephson M.A. Transplantation: pregnancy after kidney donation: more questions than answers. Nat Rev Nephrol. 2009;5(9):495-7. doi: 10.1038/nrneph.2009.129
  44. Gianfreda D, Quaglini S, Frontini G, et al. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J Autoimmun. 2017;84:46-54. doi: 10.1016/j.jaut. 2017.06.003
  45. Blom K, Odutayo A, Bramham K, Hladunewich M.A. Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines. Сlin J Am Soc Nephrol. 2017;12(11):1862-72. doi: 10.2215/CJN.00130117
  46. Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis. 2007;49 (6):753-62. doi: 10.1053/j.ajkd.2007.03.022
  47. Fischer M.J. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14(2):132-45. doi: 10.1053/ j.ackd.2007.01.004
  48. Bramham K. Diabetic Nephropathy and Pregnancy. Semin Nephrol. 2017;37(4):362-9. doi: 10.1016/j.semnephrol.2017.05.008
  49. Eswarappa M, Rakesh M, Sonika P, et al. Spectrum of renal injury in pregnancy - induced hypertension: Experience from a single center in India. Saudi J Kidney Dis Transplant. 2017;28(2):279. doi: 10.4103/ 1319-2442.202790
  50. Prakash J. The kidney in pregnancy: A journey of three decades. Indian J Nephrol. 2012;22(3):159-67. doi: 10.4103/0971-4065.98750
  51. Piccoli G.B, Fassio F, Attini R, et al. Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant. 2012;27 Suppl 3:iii111-118. doi: 10.1093/ndt/gfs302
  52. Piccoli G.B, Cabiddu G, Daidone G, et al. The children of dialysis: live - born babies from on - dialysis mothers in Italy - an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol Dial Transplant. 2014;29(8):1578-86. doi: 10.1093/ndt/gfu092
  53. Jesudason S, Grace B.S, Mc Donald S.P. Pregnancy Outcomes According to Dialysis Commencing Before or After Conception in Women with ESRD. Clin J Am Soc Nephrol. 2014;9(1):143-9. doi: 10.2215/ CJN.03560413
  54. Hladunewich M.A, Hou S, Odutayo A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol. 2014;25(5):1103-9. doi: 10.1681/ASN.2013080825
  55. Piccoli G.B, Minelli F, Versino E, et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta - regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol Dial Transplant. 2016;31(11):1915-34. doi: 10.1093 ndt/gfv395
  56. Deshpande N.A, James N.T, Kucirka L.M, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta - analysis. Am J Transplant. 2011;11(11):2388-404. doi: 10.1111/j.1600-6143.2011.03656.x
  57. Deshpande N.A, Coscia L.A, Gomez-Lobo V, et al. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6(3-4):116-25. PMC4002187.
  58. Bramham K, Nelson-Piercy C, Gao H, et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin J Am Soc Nephrol. 2013;8(2):290-8. doi: 10.2215/CJN.06170612
  59. Piccoli G.B, Cabiddu G, Attini R, et al. Outcomes of Pregnancies After Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis. Transplantation. 2017;101(10):2536-44. doi: 10.1097/TP. 0000000000001649
  60. Webster P, Lightstone L, Mc Kay D.B, Josephson M.A. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017;91(5):1047-56. doi: 10.1016/j.kint.2016.10.045
  61. Pietrzak B, Mazanowska N, Kociszewska-Najman B, et al. Successful Pregnancy Outcome after In Vitro Fertilization in a Kidney Graft Recipient: A Case Report and Literature Review. Ann Transplant. 2015;20:338-41. doi: 10.12659/AOT.893735
  62. Norrman E, Bergh C, Wennerholm U-B. Pregnancy outcome and long - term follow - up after in vitro fertilization in women with renal transplantation. Hum Reprod. 2015;30(1):205-13. doi: 10.1093/humrep/deu293
  63. Tedeschi S.K, Bermas B, Costenbader K.H. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol. 2013;149(2):211-8. doi: 10.1016/j.clim.2013.03.003
  64. Marder W, Vinet É, Somers E.C. Rheumatic autoimmune diseases in women and midlife health. Womens Midlife Health [Internet]. 2015 [cited 2017 Oct 19];1. Available from: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC5444314/
  65. Ortona E, Pierdominici M, Maselli A, et al. Sex - based differences in autoimmune diseases. Ann Ist Super Sanita. 2016;52(2):205-12. doi: 10.4415/ANN_16_02_12
  66. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16(5):847-58. PMID: 12473278.
  67. Weckerle C.E, Niewold T.B. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011;40(1):42-9. doi: 10.1007/s12016-009-8192-4
  68. Scofield R.H, Bruner G.R, Namjou B, et al. Klinefelter’s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene - dose effect from the X chromosome. Arthritis Rheum. 2008;58(8):2511-7. doi: 10.1002/art.23701
  69. Pierdominici M, Ortona E. Estrogen Impact on Autoimmunity Onset and Progression: the Paradigm of Systemic Lupus Erythematosus. Int Trends Immun. 2013;1(2):24-34.
  70. Maselli A, Conti F, Alessandri C, et al. Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti - estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus. Biol Sex Differ [Internet]. 2016 [cited 2017 Oct 19];7. Available from: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4709986/
  71. Kim S.J, Schätzle S, Ahmed S.S, et al. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the TFH cell repertoire and contributes to lupus. Nat Immunol. 2017;18(9):1016-24. doi: 10.1038/ ni.3793
  72. Langefeld C.D, Ainsworth H.C, Cunninghame Graham D.S, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8:16021. doi: 10.1038/ncomms16021
  73. Niewold T.B, Hua J, Lehman T.J.A, et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492-502. doi: 10.1038/sj.gene.6364408
  74. Tower C, Mathen S, Crocker I, Bruce I.N. Regulatory T cells in Systemic Lupus Erythematosus and Pregnancy. Am J Reprod Immunol. 2013;69(6):588-95. doi: 10.1111/aji.12081
  75. Almaani S, Meara A, Rovin B.H. Update on Lupus Nephritis. CJASN. 2016;CJN.05780616. doi: 10.2215/CJN.05780616
  76. Buyon J.P, Kim M.Y, Guerra M.M, et al. Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus. Clin J Am Soc Nephrol. 2017;12(6): 940-6. doi: 10.2215/CJN.11431116
  77. Yelin E, Yazdany J, Trupin L. Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus. Arthritis Care Res. 2017;69(6):927-32. doi: 10.1002/acr.22977
  78. Kaplowitz E.T, Ferguson S, Guerra M, et al. Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus. Arthritis Care Res. 2017;69(6):833-41. doi: 10.1002/acr.23021
  79. Myasoedova E, Crowson C.S, Kremers H.M, et al. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62(6):1576-82. doi: 10.1002/ art.27425
  80. Goemaere S, Ackerman C, Goethals K, et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol. 1990;17(12):1620-2. PMID: 2084234.
  81. De Man Y.A, Dolhain R.J.E.M, van de Geijn F.E, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241-8.
  82. Icardi A, Araghi P, Ciabattoni M, et al. Kidney involvement in rheumatoid arthritis. Reumatismo. 2003;55(2):76-85. PMID: 12874640.
  83. Anders H-J, Vielhauer V. Renal co - morbidity in patients with rheumatic diseases. Arthritis Res Ther. 201;13:222. doi: 10.1186/ ar3256
  84. Chiu H-Y, Huang H-L, Li C-H, et al. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study. PLOS ONE. 2015;10(9):e0136508. doi: 10.1371/journal.pone.0153431
  85. Vinet É, Bernatsky S, Hudson M, et al. Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Res Ther. 2014;16:R130. doi: 10.1186/ar4587
  86. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev. 2012;11(6-7):A430-436. doi: 10.1016/j.autrev.2011.11.006
  87. Penn H, Denton C.P. Diagnosis, management and prevention of scleroderma renal disease. Curr Opin Rheumatol. 2008;20(6):692-6. doi: 10.1097/BOR.0b013e3283108df7
  88. Anders H.J, Wiebecke B, Haedecke C, et al. MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis. 1999;33(4):e3. PMID: 10196034.
  89. Zakharova E.V, Makarova T.A, Stolyarevich E.S. ANCA-Associated Vasculitis in Patient with CREST-Syndrome - Case Report [Internet]. [cited 2017 Oct 19]. Available from: https://www.peertechz.com/Clinical-Nephrology/ACN-2-115.php
  90. Eckardt K-U, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158-69. doi: 10.1016/S0140-6736(13)60439-0
  91. Saran R, Robinson B, Abbott K.C, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7-8. doi: 10.1053/ j.ajkd.2016.12.004
  92. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end - stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-82. doi: 10.1016/S0140-6736(14)61601-9
  93. Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014;125:229-43; discussion 243-46.
  94. WHO. Addressing gender within primary health care reforms. In: WHO editor. Gender, women and primary health care renewal: a discussion paper [Internet]. [cited 2017 Oct 19]. Available from: http://apps.who.int/iris/bitstream/10665/44430/1/9789241564038_eng.pdf
  95. Eguavoen A.N.T, Odiagbe S.O, Obetoh G.I. The Status of Women, Sex Preference, Decision-Making and Fertility Control in Ekpoma Community of Nigeria. J Soc Sci. 2007;15(1):43-9.
  96. Halle M.P, Takongue C, Kengne A.P, et al. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrol. 2015;16:59. doi: 10.1186/s12882-015-0044-2
  97. Ajayi S, Raji Y, Bello T, et al. Unaffordability of renal replacement therapy in Nigeria. Hong Kong J Nephrol. 2016;18:15-29.
  98. Kausz A.T, Obrador G.T, Arora P, et al. Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol. 2000;11(12):2351-7. PMID: 11095658
  99. Coresh J, Byrd-Holt D, Astor B.C, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1):180-8. doi: 10.1681/ASN.2004070539
  100. Adams S.V, Rivara M, Streja E, et al. Sex Differences in Hospitalizations with Maintenance Hemodialysis. J Am Soc Nephrol. 2017;28(9):2721-8. doi: 10.1681/ASN.2016090986
  101. Ethier J, Mendelssohn D.C, Elder S.J, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23(10):3219-26. doi: 10.1093/ndt/gfn261
  102. Depner T.A. Prescribing Hemodialysis: The Role of Gender. Adv Ren Replace Ther. 2003 Jan;10(1):71-7. doi: 10.1053/jarr.2003.50007
  103. Sehgal A.R. Outcomes of renal replacement therapy among blacks and women. Am J Kidney Dis. 2000;35(4):S148-52. PMID: 10766013
  104. Jindal R.M, Ryan J.J, Sajjad I, et al. Kidney transplantation and gender disparity. Am J Nephrol. 2005;25(5):474-83. doi: 10.1159/000087920
  105. Couchoud C, Bayat S, Villar E, et al. REIN registry. A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation. 2012;94(5):513-9.
  106. Liu G, Li X, Liu T, et al. Gender disparity of living donor renal transplantation in East China. Clin Transplant. 2013;27(1):98-103. doi: 10.1111/ctr.12003
  107. Naghibi O, Naghibi M, Nazemian F. Gender disparity in kidney transplantation. Saudi J Kidney Dis Transpl. 2008;19(4):545-50. PMID: 18580010
  108. Bal M.M, Saikia B. Gender bias in renal transplantation: are women alone donating kidneys in India? Transplant Proc. 2007;39(10):2961-3. doi: 10.1016/j.transproceed.2007.08.089
  109. Hogan J, Couchoud C, Bonthuis M, et al. Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data from the ESPN/ERA-EDTA Registry. Am J Transplant. 2016;16(7):2097-105. doi: 10.1111/ajt.13723
  110. Gillespie A, Hammer H, Kolenikov S, et al. Sex Differences and Attitudes toward Living Donor Kidney Transplantation among Urban Black Patients on Hemodialysis. Clin J Am Soc Nephrol. 2014;9(10):1764-72. doi: 10.2215/CJN.12531213
  111. Salter M.L, Mc Adams-Demarco M.A, Law A, et al. Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. J Am Geriatr Soc. 2014;62(5):843-9. doi: 10.1111/ jgs.12801
  112. Piccoli G.B, Attini R, Cabiddu G, et al. Maternal - fetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy? J Autoimmun. 2017;79:91-8. doi: 10.1016/j. jaut.2017.01.008
  113. Seeger H, Salfeld P, Eisel R, et al. Complicated pregnancies in inherited distal renal tubular acidosis: importance of acid - base balance. J Nephrol. 2017;30(3):455-60. doi: 10.1007/s40620-016-0370-x
  114. Yefet E, Tovbin D, Nachum Z. Pregnancy outcomes in patients with Alport syndrome. Arch Gynecol Obstet. 2016;293(4):739-47. doi: 10.1007/s00404-015-3893-9

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies